Basic Information
ID: ALA2039181
Type: Functional
Description: Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by MTT assay
Format: BAO_0000218
Organism: Human immunodeficiency virus 1
Strain: 3B
Cell type: MT4
Target: Human immunodeficiency virus 1(ALA378)
Document: ALA2034874
Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathogenicity after 4 days by MTT assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA2039181
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 315.68 | 4.07 | 4.07 |
| 296.33 | 3.45 | 3.45 |
| 326.35 | 3.46 | 3.46 |
| 236.27 | 3.43 | 3.43 |
| 270.72 | 4.09 | 4.09 |
| 304.27 | 4.45 | 4.45 |
| 266.30 | 3.44 | 3.44 |
| 268.32 | 3.29 | 3.29 |
| 298.34 | 3.30 | 3.30 |
| 328.37 | 3.31 | 3.31 |
| 251.29 | 3.43 | 3.43 |
| 285.73 | 4.08 | 4.08 |
| 319.29 | 4.45 | 4.45 |
| 281.31 | 3.44 | 3.44 |
| 311.34 | 3.45 | 3.45 |
| 341.37 | 3.45 | 3.45 |
| 293.33 | 2.62 | 2.62 |
| 327.78 | 3.28 | 3.28 |
| 361.33 | 3.64 | 3.64 |
| 323.36 | 2.63 | 2.63 |
| 353.38 | 2.64 | 2.64 |
| 309.40 | 2.79 | 2.79 |
| 343.84 | 3.44 | 3.44 |
| 377.39 | 3.81 | 3.81 |
| 339.42 | 2.80 | 2.80 |
| 369.45 | 2.80 | 2.80 |
| 405.50 | 4.61 | 4.61 |
| 435.53 | 4.62 | 4.62 |
| 318.42 | 5.41 | 5.41 |
| 352.87 | 6.06 | 6.06 |
| 386.42 | 6.43 | 6.43 |
| 348.45 | 5.42 | 5.42 |
| 378.47 | 5.43 | 5.43 |
| 308.38 | 5.00 | 5.00 |
| 319.41 | 4.81 | 4.81 |
| 226.24 | 3.03 | 3.03 |
| 242.32 | 3.81 | 3.81 |
| 375.48 | 4.60 | 4.60 |
| 409.92 | 5.25 | 5.25 |
| 443.47 | 5.62 | 5.62 |
| 365.44 | 4.19 | 4.19 |
| 376.46 | 4.00 | 4.00 |
| 283.29 | 2.22 | 2.22 |
| 299.38 | 3.00 | 3.00 |
| 391.54 | 4.77 | 4.77 |
| 425.99 | 5.42 | 5.42 |
| 459.54 | 5.78 | 5.78 |
| 421.57 | 4.77 | 4.77 |
| 451.60 | 4.78 | 4.78 |
| 381.51 | 4.36 | 4.36 |
| 392.53 | 4.16 | 4.16 |
| 299.36 | 2.38 | 2.38 |
| 315.45 | 3.17 | 3.17 |